Press Releases

The Broad Institute only issues press releases relative to major scientific findings and events. Below is a chronological archive of past releases.
  • Genetic study provides first-ever insight into biological origin of schizophrenia

    January 26th, 2016
    Landmark analysis reveals excessive “pruning” of connections between neurons in brain predisposes to schizophrenia
    Read Full Story
  • Broad Institute Genomic Services partners with Takeda Pharmaceuticals to offer genomic insight into the recently approved therapeutic NINLARO® (ixazomib)

    January 22nd, 2016
    Broad Institute Genomic Services has partnered with Takeda Pharmaceutical Company Limited to perform genomic analysis on patient samples from a Phase 3 clinical trial of NINLARO® (ixazomib), an oral proteasome inhibitor that was recently approved by the U.S. Food and Drug Administration (FDA), indicated in combination with lenalidomide and dexamethasone, for the treatment of patients with multiple myeloma who have received at least one...
    Read Full Story
  • Broad Institute awarded grants to propel studies of common, rare diseases

    January 14th, 2016
    NGHRI grants will fund two centers at the Broad that harness genome sequencing to tackle human disease
    Read Full Story
  • Genome misfolding unearthed as new path to cancer

    December 23rd, 2015
    IDH mutations disrupt how the genome folds, bringing together disparate genes and regulatory controls to spur cancer growth
    Read Full Story
  • Broad, MIT scientists overcome key CRISPR-Cas9 genome editing hurdle

    December 1st, 2015
    Broad, MIT team re-engineers Cas9 system to dramatically cut down on editing errors
    Read Full Story